If the panel’s recommendations are adopted by the FDA, that would mean that Dexcom G5 users would not need to do a separate fingerstick with a meter to get a blood sugar reading for basal and bolus insulin dosing; they would, however, still need to do daily fingersticks to calibrate the device. European G5 users already are cleared to use the CGM in this manner; in January 2015, the European Medicine Agency, the EU counterpart to FDA, cleared the G5 for insulin dosing.